Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 6

    1.

    How do we know when a lymph node dissection is adequate?

    Sondak VK.

    Ann Surg Oncol. 2011 Sep;18(9):2419-21. No abstract available.

    PMID:
    21537859
    [PubMed - indexed for MEDLINE]
    2.

    Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.

    Essa S, Reichrath S, Mahlknecht U, Montenarh M, Vogt T, Reichrath J.

    Anticancer Res. 2012 Jan;32(1):383-9.

    PMID:
    22213330
    [PubMed - indexed for MEDLINE]
    3.

    BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance.

    Alcalá AM, Flaherty KT.

    Clin Cancer Res. 2012 Jan 1;18(1):33-9.

    PMID:
    22215904
    [PubMed - indexed for MEDLINE]
    4.

    Chronology of metastasis in cutaneous melanoma: growth rate model.

    Tejera-Vaquerizo A, Nagore E, Meléndez JJ, López-Navarro N, Martorell-Calatayud A, Herrera-Acosta E, Traves V, Guillén C, Herrera-Ceballos E.

    J Invest Dermatol. 2012 Apr;132(4):1215-21. doi: 10.1038/jid.2011.433. Epub 2012 Jan 5.

    PMID:
    22217744
    [PubMed - indexed for MEDLINE]
    5.

    Melanoma: new insights and new therapies.

    Nikolaou VA, Stratigos AJ, Flaherty KT, Tsao H.

    J Invest Dermatol. 2012 Mar;132(3 Pt 2):854-63. doi: 10.1038/jid.2011.421. Epub 2012 Jan 5. Review.

    PMID:
    22217739
    [PubMed - indexed for MEDLINE]
    6.

    MicroRNA regulation of melanoma progression.

    Bonazzi VF, Stark MS, Hayward NK.

    Melanoma Res. 2012 Apr;22(2):101-13.

    PMID:
    22209751
    [PubMed - in process]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk